SUB CATEGORY
GEOGRAPHY
PUBLISH DATE
The epidermolysis bullosa care and treatment market will grow at a CAGR of 7.10% to be valued at US$3861.27 billion in 2030 from US$2740.459 billion in ...
The Botulinum Toxins Market, valued at US$12.181 billion in 2030 from US$8.590 billion in 2025, is projected to grow at a CAGR of 7.23% through 2030. Botulinum ...
The global infection prevention product and services market is estimated to grow at a CAGR of 5.66% to reach a market size of US$225.847 billion in 2030 ...
The IGA nephropathy disease treatment market is projected to grow from US$315.914 million in 2025 to US$591.844 million in 2030 at a CAGR of 13.38%. The ...
The acute kidney injury (AKI) disease treatment market is predicted to grow at a CAGR of 7.50% from US$2.004 billion in 2025 to US$2.875 billion by 2030. The ...
The eosinophilic esophagitis disease treatment market is projected to grow at a CAGR of 8.15% over the forecast period, increasing from US$504.625 million ...
The intracranial aneurysm market is expected to grow at a CAGR of 8.41% from US$1.411 billion in 2022 to US$2.484 billion in 2029. A ...
The HPV-associated disorders market is expected to witness significant growth during the forecasted period. More than 100 viruses make up the human papillomavirus ...
The Alpha-1 antitrypsin deficiency treatment market is anticipated to expand at a high CAGR over the forecast period. The market for treatments for Alpha-1 ...
The Idiopathic pulmonary fibrosis market is evaluated at US$3.459 billion for the year 2022 growing at a CAGR of 11.87% reaching the market size of US$7.585 ...